LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 50.36 84.90 63 5651 0.0111 -0.0481
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 50.36 84.90 1846 5651 0.3267 0.6627
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 50.36 84.90 2349 5651 0.4157 0.7302
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 50.36 84.90 2385 5651 0.4220 0.7345
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.06 84.90 47 5990 0.0078 -0.0918
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.06 84.90 2546 5990 0.4250 0.7399
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.06 84.90 68 5990 0.0114 -0.0355
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.06 84.90 1915 5990 0.3197 0.6610
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.06 84.90 2445 5990 0.4081 0.7284
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 52.06 84.90 2475 5990 0.4131 0.7319
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.77 84.90 19 6252 0.0030 -0.2144
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.77 84.90 2621 6252 0.4192 0.7384
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.77 84.90 82 6252 0.0131 -0.0056
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.77 84.90 2017 6252 0.3226 0.6665
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.77 84.90 2591 6252 0.4144 0.7352
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.77 84.90 2619 6252 0.4189 0.7382
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 55.48 84.90 29 6567 0.0044 -0.1574
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 55.48 84.90 2784 6567 0.4239 0.7443
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 55.48 84.90 97 6567 0.0148 0.0215
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 55.48 84.90 2092 6567 0.3185 0.6666
MN20160318_Q02
H20
MCF 10A-H2B-mCherry Dasatinib
0.31623
 55.48 84.90 2714 6567 0.4132 0.7372
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 55.48 84.90 2748 6567 0.4184 0.7407
MN20160318_Q02
K06
MCF 10A-H2B-mCherry Dasatinib
0.31623
 57.18 84.90 51 6963 0.0073 -0.0770
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 57.18 84.90 2887 6963 0.4146 0.7414
MN20160318_Q02
H19
MCF 10A-H2B-mCherry Dasatinib
0.31623
 57.18 84.90 90 6963 0.0129 0.0092
MN20160318_Q02
H20